Abstract
Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have